2825 - Megan Bugg Global Rhabdo Research Laboratory

Megan Bugg Global Rhabdomyosarcoma Research Laboratory at cc-TDI

Many of you closely followed Megan Bugg’s 7-year cancer journey as she graciously and openly shared her battle with Alveolar Rhabdomyosarcoma (ARMS). Since her own diagnosis, Megan made it her mission to meet the need for childhood cancer research by becoming a passionate advocate raising awareness and fundraising for the cause.

Here at cc-TDI we affectionately refer to Megan as the heart and soul of our lab for her passion and advocacy she showed the childhood cancer research community. Over the past five years, and with the unwavering support from the Team Megan Bugg (now the Megan's Mission Foundation) community, Megan raised more than $1.5 million in support of cancer research discoveries, international collaborations, and clinical trials – all while fighting for her life.

After a seven year battle with stage 4 Alveolar Rhabdomyosarcoma, Megan tragically passed away on March 9, 2022. However, her life and legacy lives on as she touched countless lives with her message of courage, determination, positivity, and hope. When faced with her own personal battle with ARMS, Megan was committed to making her fight about something bigger than herself. Her mission was to end childhood cancer so that no more kids had to go through what she went through at the hands of this vicious disease.

Megan’s steadfast support, both as cc-TDI’s Resident Citizen Scientist and as our champion advocate, is the cornerstone for the RMS work being done in the lab. To honor her legacy, cc-TDI embarked on a new, ongoing initiative with the development of the “Megan Bugg Global Rhabdomyosarcoma Research Laboratory” at cc-TDI. This allows cc-TDI scientists to continue working daily to fulfill “Megan’s Mission” to change outcomes for children fighting RMS - trying everything possible to develop safe, effective, and less toxic treatment options, so that children can go on to live healthy lives after treatment.

Your gift furthers our work with immunotherapy for RMS, the Citizen Scientist Project, and pushing entinostat for RMS further along the clinical trial pipeline. Megan wanted to be remembered as the “kid who did something”. We ask that you consider supporting the “Megan Bugg Global Rhabdomyosarcoma Research Laboratory” at cc-TDI as we fulfill “Megan’s Mission” and continue our fight against this disease.

To see “Megan’s Mission”, please watch this video at: https://youtu.be/8tUIBIPLAao